This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors are employed by the Tufts Centre for the Study of Drug Development (Tufts CSDD), a non-profit, academic unit within Tufts University School of Medicine. Some of Tufts CSDD's general funding is provided by unrestricted grants from biopharmaceutical companies and associated service providers. The funding for the 2010 and 2015 surveys was provided in part by the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Personalized Medicine Coalition (PMC), respectively.
Related links
PowerPoint slides
Supplementary information
Supplementary information S1 (box)
Survey methodology (PDF 122 kb)
Rights and permissions
About this article
Cite this article
Milne, CP., Cohen, J. & Chakravarthy, R. Where is personalized medicine in industry heading?. Nat Rev Drug Discov 14, 812–813 (2015). https://doi.org/10.1038/nrd4759
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4759
- Springer Nature Limited
This article is cited by
-
The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
Journal of Experimental & Clinical Cancer Research (2017)